Novo Nordisk Boots CEO After Stock Falls 50%. It’s an Unusual Move for the Wegovy Drugmaker.
Latest News
- IO Biotech price target raised to $14 from $12 at H.C. Wainwright
- Jana Partners liquidated position in Wolfspeed in Q1, filing
- Bitfarms mining business ‘significantly undervalued,’ says H.C. Wainwright
- Mortgage rates move higher on positive economic news
- Analyst Report: Walmart Inc
- TMD Energy reports 2024 net income $1.9M vs. $2.0M last year